Stephen Michael Schleicher MD
Cosmetic Dermatology, Dermatologic Surgery
DermDOX Center for Dermatology
Join to View Full Profile
8 Brookhill Sq SSte 2ASugarloaf, PA 18249
Phone+1 570-459-0029
Fax+1 570-454-5757
Dr. Schleicher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stephen Schleicher is a dermatologist based in Sugarloaf, PA, with subspecialties in cosmetic dermatology and dermatologic surgery. He completed his medical education at Drexel University College of Medicine in 1976, followed by an internal medicine internship at Rutgers Health/Monmouth Medical Center, and a dermatology residency at Temple University Hospital. He has expertise in psoriasis, dermatologic surgery, cosmetic dermatology, and teledermatology. Dr. Schleicher has contributed to several publications, including studies on skin disease treatments and acne scars, with work published in journals like Nature Communications and Dermatology and Therapy. He has been recognized with the CMS Meaningful Use Stage 1 Certification and is a Fellow of the American Academy of Dermatology.
Education & Training
Temple University HospitalResidency, Dermatology, 1977 - 1980
Rutgers Health/Monmouth Medical CenterInternship, Internal Medicine, 1976 - 1977
Drexel University College of MedicineClass of 1976
Certifications & Licensure
FL State Medical License 2002 - 2027
PA State Medical License 1977 - 2026
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EMA EMR, Modernizing Medicine, Inc., 2013
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 2 citationsThe regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-...Jonathan I Silverberg, David Rosmarin, Raj Chovatiya, Thomas Bieber, Stephen Schleicher
Nature Communications. 2024-10-25 - Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson
Dermatology and Therapy. 2024-02-01 - 10 citationsTrifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson
Dermatology and Therapy. 2023-12-01
Press Mentions
Top 5 Phase I Dermatology Clinical Trial SitesDecember 12th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
